Copyright
©The Author(s) 2015.
World J Gastroenterol. Jun 7, 2015; 21(21): 6604-6612
Published online Jun 7, 2015. doi: 10.3748/wjg.v21.i21.6604
Published online Jun 7, 2015. doi: 10.3748/wjg.v21.i21.6604
Table 3 Interaction between CA19-9 and PC-594 n (%)
| CA19-9 (U/mL) | PC-594 (μmol/L) | PaC | Control |
| Abnormal | 54 (64) | 5 (5) | |
| Abnormal | 72 (86) | 9 (9) | |
| Abnormal | Abnormal | 48 (57) | 0 (0) |
| Abnormal | Normal | 6 (7) | 5 (5) |
| Normal | Abnormal | 24 (29) | 9 (9) |
| Normal | Normal | 6 (7) | 85 (86) |
- Citation: Ritchie SA, Chitou B, Zheng Q, Jayasinghe D, Jin W, Mochizuki A, Goodenowe DB. Pancreatic cancer serum biomarker PC-594: Diagnostic performance and comparison to CA19-9. World J Gastroenterol 2015; 21(21): 6604-6612
- URL: https://www.wjgnet.com/1007-9327/full/v21/i21/6604.htm
- DOI: https://dx.doi.org/10.3748/wjg.v21.i21.6604